Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the quarter ended March 31, 2013, and also commented on certain corporate accomplishments and plans.
Help employers find you! Check out all the jobs and post your resume.
